Relationship between acquired deficiency of vitamin K-dependent clotting factors and hemorrhage

Rui Yang , Xiaoping Zhang , Wenning Wei , Mei Hong , Yan Yang , Yu Hu

Current Medical Science ›› 2010, Vol. 30 ›› Issue (3) : 312 -317.

PDF
Current Medical Science ›› 2010, Vol. 30 ›› Issue (3) : 312 -317. DOI: 10.1007/s11596-010-0348-1
Article

Relationship between acquired deficiency of vitamin K-dependent clotting factors and hemorrhage

Author information +
History +
PDF

Abstract

This study examined the changes of activities of vitamin K-dependent clotting factors (VKDCF) under various pathological conditions and explored the relationship between acquired deficiency of VKDCFs and hemorrhage. Clinical data of 35 patients who were diagnosed as having acquired deficiency of VKDCF were retrospectively analyzed. Coagulation factors involved in the intrinsic and extrinsic pathways were detected in these patients and 41 control subjects. The results showed that the average activities of VKDCFs were decreased in the patients in comparison to the control subjects and significantly increased after treatment of these patients with vitamin K and blood products. Multivariate regression analysis indicated that decreased activity of VKDCF was not an independent risk factor for bleeding disorders owing to deficiency or metabolic disturbance of vitamin K. It was concluded that acquired deficiency of VKDCF occurs under a variety of pathologic conditions and is closely associated with hemorrhagic events. Administration of vitamin K and transfusion of blood products containing high concentrations of VKDCFs helps alleviate the hemorrhagic diseases.

Keywords

coagulation factor / deficiency / hemorrhage / vitamin K

Cite this article

Download citation ▾
Rui Yang, Xiaoping Zhang, Wenning Wei, Mei Hong, Yan Yang, Yu Hu. Relationship between acquired deficiency of vitamin K-dependent clotting factors and hemorrhage. Current Medical Science, 2010, 30(3): 312-317 DOI:10.1007/s11596-010-0348-1

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

CranenburgE.C., SchurgersL.J., VermeerC., VitaminK.. the coagulation vitamin that became omnipotent. Thromb Haemost, 2007, 98(1): 120-125

[2]

HarringtonD.J., WesternH., Seton-JonesC., et al.. A study of the prevalence of vitamin K deficiency in patients with cancer referred to a hospital palliative care team and its association with abnormal haemostasis. J Clin Pathol, 2008, 61(4): 537-540

[3]

ShearerM.J.. Vitamin K metabolism and nutriture. Blood Rev, 1992, 6(2): 92-104

[4]

OldenburgJ., WatzkaM., RostS., et al.. VKORC1: Molecular target of coumarins. J Thromb Haemost, 2007, 5(Suppl1): 1-6

[5]

WallinR., WajihN., HutsonS.M.. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors. Vitam Horm, 2008, 78: 227-246

[6]

BlanchardR.A., FurieB.C., JorgensenM., et al.. Acquired vitamin K-dependent carboxylation deficiency in liver disease. N Engl J Med, 1981, 305(5): 242-248

[7]

FurieB., FurieB.C.. Mechanisms of Thrombus Formation. N Engl J Med, 2008, 359(9): 938-949

[8]

DamH., SchonheyderF.. A deficiency disease in chicks resembling scurvy. Biochem J, 1934, 28(4): 1355-1359

[9]

FurieB., FurieB.C.. Molecular and cellular biology of blood coagulation. N Engl J Med, 1992, 326(12): 800-806

[10]

RapaportS.I.. Coagulation problems in liver disease. Blood Coagul Fibrinolysis, 2000, 11(Suppl1): S69-74

[11]

LismanT., LeebeekF.W., de GrootP.G.. Haemostatic abnormalities in patients with liver disease. J Hepatol, 2002, 37(2): 280-287

[12]

AmiralJ., FareedJ.. Thromboembolic diseases: biochemical mechanisms and new possibilities of biological diagnosis. Semin Thromb Hemost, 1996, 22(Suppl1): 41-48

[13]

Penning-van BeestF.J., Gómez GarcíaE.B., van der MeerF.J., et al.. Levels of vitamin K-dependent procoagulant and anticoagulant proteins in over-anticoagulated patients. Blood Coagul Fibrinolysis, 2002, 13(8): 733-739

[14]

SenzoloM., BurraP., CholongitasE., et al.. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol, 2006, 12(48): 7725-7736

[15]

WiedermannC.J., StocknerI.. Warfarin-induced bleeding complications -clinical presentation and therapeutic options. Thromb Res, 2008, 122(Suppl2): S13-18

[16]

van HasseltP.M., de KoningT.J., KvistN., et al.. Netherlands Study Group for Biliary Atresia Registry. Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries. Pediatrics, 2008, 121(4): e857-863

[17]

PapadopoulosV., FilippouD., ManolisE., et al.. Haemostasis impairment in patients with obstructive jaundice. J Gastrointestin Liver Dis, 2007, 16(2): 177-186

[18]

PereiraS.P., RowbothamD., FittS., et al.. Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. J Hepatol, 2005, 42(3): 365-370

[19]

KerrR., NewsomeP., GermainL., et al.. Effects of acute liver injury on blood coagulation. J Thromb Haemost, 2003, 1(4): 754-759

[20]

WongR.S., ChengG., ChanN.P., et al.. Use of cefoperazone still needs a caution for bleeding from induced vitamin K deficiency. Am J Hematol, 2006, 81(1): 76

[21]

RashidM., DurieP., AndrewM., et al.. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr, 1999, 70(3): 378-382

[22]

ChenC.S., CumblerE.U., TrieblingA.T.. Coagulopathy due to celiac disease presenting as intramuscular hemorrhage. J Gen Intern Med, 2007, 22(11): 1608-1612

[23]

SundaramA., KoutkiaP., ApovianC.M.. Nutritional management of short bowel syndrome in adults. J Clin Gastroenterol, 2002, 34(3): 207-220

[24]

PrenticeC.R.. Acquired coagulation disorders. Clin Haematol, 1985, 14(2): 413-442

[25]

KuzuM.A., KaleI.T., CölC., et al.. Obstructive jaundice promotes bacterial translocation in humans. Hepatogastroenterology, 1999, 46(28): 2159-2164

[26]

BrunoG.R., HowlandM.A., McMeekingA., et al.. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Ann Emerg Med, 2000, 36(3): 262-267

[27]

SpahrJ.E., MaulJ.S., RodgersG.M.. Superwarfarin poisoning: a report of two cases and review of the literature. Am J Hematol, 2007, 82(7): 656-660

[28]

GirolamiA., ScandellariR., ScapinM., et al.. Congenital bleeding disorders of the vitamin K-dependent clotting factors. Vitam Horm, 2008, 78: 281-374

[29]

Ben-TalO., ZwangE., EichelR., et al.. Vitamin K-dependent coagulation factors and fibrinogen levels in FFP remain stable upon repeated freezing and thawing. Transfusion, 2003, 43(7): 873-877

[30]

LeissingerC.A., BlattP.M., HootsW.K., et al.. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol, 2008, 83(2): 137-143

[31]

HoffmanC.J., LawsonW.E., MillerR.H., et al.. Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb, 1994, 14(11): 1737-1740

[32]

KamaliF., EdwardsC., WoodP., et al.. Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans. Am J Hematol, 2001, 68(3): 159-163

AI Summary AI Mindmap
PDF

102

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/